ATE245169T1 - Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben - Google Patents

Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben

Info

Publication number
ATE245169T1
ATE245169T1 AT95944434T AT95944434T ATE245169T1 AT E245169 T1 ATE245169 T1 AT E245169T1 AT 95944434 T AT95944434 T AT 95944434T AT 95944434 T AT95944434 T AT 95944434T AT E245169 T1 ATE245169 T1 AT E245169T1
Authority
AT
Austria
Prior art keywords
age
advanced glycosylation
monoclonal antibodies
monoclonal antibody
biological samples
Prior art date
Application number
AT95944434T
Other languages
English (en)
Inventor
Henry W Founds
Homayoun Sadeghi
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/367,507 external-priority patent/US5744318A/en
Application filed by Alteon Inc filed Critical Alteon Inc
Application granted granted Critical
Publication of ATE245169T1 publication Critical patent/ATE245169T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT95944434T 1994-12-30 1995-12-29 Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben ATE245169T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/367,507 US5744318A (en) 1994-12-30 1994-12-30 Monoclonal antibody for the detection of advanced glycosylation endproducts in biological samples
US08/483,186 US5698197A (en) 1994-12-30 1995-06-07 Monoclonal antibody specific for advanced glycosylation endproducts in biological samples
PCT/US1995/017037 WO1996020958A1 (en) 1994-12-30 1995-12-29 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
US08/581,724 US5892000A (en) 1994-12-30 1995-12-29 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples

Publications (1)

Publication Number Publication Date
ATE245169T1 true ATE245169T1 (de) 2003-08-15

Family

ID=27408819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95944434T ATE245169T1 (de) 1994-12-30 1995-12-29 Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben

Country Status (10)

Country Link
US (2) US5892000A (de)
EP (1) EP0801658B1 (de)
JP (1) JP2002514888A (de)
AT (1) ATE245169T1 (de)
AU (1) AU693992B2 (de)
CA (1) CA2208411A1 (de)
DE (1) DE69531311T2 (de)
ES (1) ES2203651T3 (de)
IL (1) IL116617A (de)
WO (1) WO1996020958A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024372A1 (en) * 1995-12-29 1997-07-10 Alteon Inc. 6-(n-carboxymethylamino)caproate, salts thereof and methods of use therefor
US7071298B2 (en) * 1997-02-05 2006-07-04 Fox Chase Cancer Center Compounds and methods for treating glycogen storage disease and other pathological conditions resulting from formation of age-proteins
JPH11258238A (ja) * 1998-03-10 1999-09-24 Tokuyama Corp 免疫学的凝集測定用試薬キット
WO1999064463A1 (en) * 1998-06-09 1999-12-16 Alteon Inc. Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples
FR2798735B1 (fr) * 1999-09-17 2001-11-23 Serobiologiques Lab Sa Procede d'evaluation et de suivi du vieillissement tissulaire
CN102037119B (zh) * 2008-05-23 2015-06-24 Siwa有限公司 促进再生的方法、组合物及设备
WO2012047629A2 (en) 2010-09-27 2012-04-12 Siwa Corporation Selective removal of age-modified cells for treatment of ather0sclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
AU2015318036B2 (en) 2014-09-19 2021-07-01 Siwa Corporation Anti-AGE antibodies for treating inflammation and auto-immune disorders
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
IL283726B2 (en) 2016-02-19 2025-05-01 Siwa Corp A preparation containing an antibody to advanced glycation end products (AGE) for use in the treatment of breast cancer
EP3443007A1 (de) 2016-04-15 2019-02-20 Siwa Corporation Anti-age-antikörper zur behandlung von neurodegenerativen erkrankungen
US11213585B2 (en) 2016-06-23 2022-01-04 Siwa Corporation Vaccines for use in treating various diseases and disorders
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
BR112019021471A2 (pt) 2017-04-13 2020-05-12 Siwa Corporation Anticorpo monoclonal humanizado de produto final da glicação avançada
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications
CN110208543A (zh) * 2019-06-06 2019-09-06 威海威高生物科技有限公司 血管内皮生长因子检测试剂盒及其使用方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869534A (en) * 1992-05-21 1999-02-09 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
US5624804A (en) * 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products

Also Published As

Publication number Publication date
IL116617A0 (en) 1996-09-12
IL116617A (en) 2001-09-13
DE69531311D1 (de) 2003-08-21
EP0801658A1 (de) 1997-10-22
JP2002514888A (ja) 2002-05-21
CA2208411A1 (en) 1996-07-11
AU4648396A (en) 1996-07-24
WO1996020958A1 (en) 1996-07-11
US5892000A (en) 1999-04-06
ES2203651T3 (es) 2004-04-16
USRE39138E1 (en) 2006-06-20
EP0801658B1 (de) 2003-07-16
DE69531311T2 (de) 2004-04-22
AU693992B2 (en) 1998-07-09

Similar Documents

Publication Publication Date Title
DE69531311D1 (de) Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben
IL149062A0 (en) Improved method for detecting acid resistant microorganisms in the stool
US20070269835A1 (en) Reagent for determining laminin 5 antigen in biological sample and assay method
AU7210994A (en) Monoclonal antibodies against the alpha pdgf receptor and uses thereof
AU1157100A (en) Detection of acid-resistant micro-organisms in a stool
IL97653A0 (en) Catalytic antibody components
CA2068222A1 (en) Monoclonal antibodies
IL154000A (en) A method that uses antibodies to diagnose arthritis
JP2007277263A (ja) カルボキシメチル化タンパク質に対する抗体
DE69024043D1 (de) Monoklonaler antikörper mit erkennungsspezifität für ein glykoprotein des globulären membran-mucin-antigens aus menschlichem milchfett.
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
WO2026006472A3 (en) Compositions of il-1r1 antibodies and methods of producing and using the same
Lewis et al. Monoclonal antibodies reacting with the interleukin 1 receptor define a multi‐molecular complex
CA2488127A1 (en) Antibodies directed against prothrombin fragment f1+2, the preparation and use thereof
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
ES2151646T3 (es) Procedimiento para la identificacion o dosificacion inmunologica de antigenos polipeptidicos.
WO2025188810A8 (en) Anti-human pax8 antibody for in vitro diagnostic use by immunohistochemistry
WO2001044299A3 (de) Antikörper und verfahren zu ihrer herstellung, deren verwendung, sowie immunisierungscocktails, immunoassay-sets und peptide
KR890009417A (ko) 모노크로날 항체의 제조방법 및 그것의 이용방법
WO2004029094B1 (en) Monoclonal antibody specific for human mitochondrial adenylate kinase isozyme 3
JPS6459068A (en) Method for measuring human thyroxin binding globulin
JP2006238747A (ja) 抗サリバリウスモノクローナル抗体を産出する細胞株、その製造方法、それにより産出されたモノクローナル抗体、およびそれにより産出されたモノクローナル抗体を含むキット
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns
BG48880A1 (en) Hybrodomic cell line mus musculus b 6/3, secretizing monoclonal antibodies against rickettsia conorii

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties